The biggest disadvantage of CEA as a target is that it is readily cleaved from the cell surface and so shed into the blood stream from tumours, either directly or via the lymphatics, which is why the level of serum CEA has been used in the clinic as a marker for screening and recurrence, especially of colorectal cancer (Chau et al, 2004). Here, CEACAM5 is linked to neoplasm.